Mizuho Maintains Outperform Rating on Chemours, Lowers Price Target to $18
4 days ago
Mizuho maintained its Outperform rating for Chemours but lowered the price target to $18 due to market challenges, noting the stock remains moderately undervalued.
Show all 112 updates